Clinical Trial Update: Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating the exposure-response relationship of golimumab using serum trough levels in ulcerative colitis; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Golimumab (golimumab)

Snippet

Sponsor: Guy's and St Thomas' NHS Foundation Trust | Conditions: Ulcerative Colitis | Phase 4 | Status: COMPLETED | Results posted: 2021-07-01